These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 30101875
21. Primary omental gastrointestinal stromal tumor (GIST). Todoroki T, Sano T, Sakurai S, Segawa A, Saitoh T, Fujikawa K, Yamada S, Hirahara N, Tsushima Y, Motojima R, Motojima T. World J Surg Oncol; 2007 Jun 12; 5():66. PubMed ID: 17565683 [Abstract] [Full Text] [Related]
23. Diagnostic relevance of overexpressions of PKC-θ and DOG-1 and KIT/PDGFRA gene mutations in extragastrointestinal stromal tumors: a Korean six-centers study of 28 cases. Kim KH, Nelson SD, Kim DH, Choi KU, Kim SJ, Min KW, Jang KS, Paik SS, Oh YH, Chae SW, Sohn JH, Kim HJ, Cho YK, Kim BI, Park DI, Sohn CI, Oh S, Choi SH, Choi YJ, Woo HY, Park YL, Park SJ, Lee SH, Ryu S, DO SI, Kang G, Kim K, Cho YH, Pyo JS. Anticancer Res; 2012 Mar 12; 32(3):923-37. PubMed ID: 22399613 [Abstract] [Full Text] [Related]
24. [c-kit and PDGFRA mutations in 60 cases of gastrointestinal stromal tumors (GISTs)]. He HY, Xiang YN, Li Y, Zhong HH, Wu BQ, Zheng J. Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun 18; 37(3):320-4. PubMed ID: 15968329 [Abstract] [Full Text] [Related]
27. Clinical characteristics and treatment outcome in a large multicentre observational cohort of PDGFRA exon 18 mutated gastrointestinal stromal tumour patients. Farag S, Somaiah N, Choi H, Heeres B, Wang WL, van Boven H, Nederlof P, Benjamin R, van der Graaf W, Grunhagen D, Boonstra PA, Reyners AK, Gelderblom H, Steeghs N. Eur J Cancer; 2017 May 18; 76():76-83. PubMed ID: 28284172 [Abstract] [Full Text] [Related]
28. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases. Miettinen M, Sobin LH, Lasota J. Am J Surg Pathol; 2009 Sep 18; 33(9):1267-75. PubMed ID: 19440146 [Abstract] [Full Text] [Related]
29. [c-Kit and PDGFRA mutations and clinico-morphological features of gastrointestinal stromal tumors]. Beliakov IS, Anurova OA, Snigur PV, Tsyganova IV, Sel'chuk VIu, Mazurenko NN. Vopr Onkol; 2007 Sep 18; 53(6):677-81. PubMed ID: 18416137 [Abstract] [Full Text] [Related]
31. Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors. Rossi S, Sbaraglia M, Dell'Orto MC, Gasparotto D, Cacciatore M, Boscato E, Carraro V, Toffolatti L, Gallina G, Niero M, Pilozzi E, Mandolesi A, Sessa F, Sonzogni A, Mancini C, Mazzoleni G, Romeo S, Maestro R, Dei Tos AP. Oncotarget; 2016 May 24; 7(21):30109-18. PubMed ID: 27097112 [Abstract] [Full Text] [Related]
32. [Status and clinical implication of c-kit and PDGFRA mutations in 165 cases of gastrointestinal stromal tumor (GIST)]. He HY, Fang WG, Zhong HH, Li Y, Zheng J, Du J, Heng WJ, Wu BQ. Zhonghua Bing Li Xue Za Zhi; 2006 May 24; 35(5):262-6. PubMed ID: 16776995 [Abstract] [Full Text] [Related]
33. Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (GIST) Harboring the Rare D842V Mutation in PDGFRA Gene. Indio V, Astolfi A, Tarantino G, Urbini M, Patterson J, Nannini M, Saponara M, Gatto L, Santini D, do Valle IF, Castellani G, Remondini D, Fiorentino M, von Mehren M, Brandi G, Biasco G, Heinrich MC, Pantaleo MA. Int J Mol Sci; 2018 Mar 04; 19(3):. PubMed ID: 29510530 [Abstract] [Full Text] [Related]
34. Intratumoral KIT mutational heterogeneity and recurrent KIT/ PDGFRA mutations in KIT/PDGFRA wild-type gastrointestinal stromal tumors. Gao J, Li J, Li Y, Li Z, Gong J, Wu J, Liu N, Dong B, Qi C, Li J, Shen L. Oncotarget; 2016 May 24; 7(21):30241-9. PubMed ID: 26848617 [Abstract] [Full Text] [Related]
35. Rhabdoid morphology in gastrointestinal stromal tumours (GISTs) is associated with PDGFRA mutations but does not imply aggressive behaviour. Schaefer IM, Ströbel P, Cameron S, Beham A, Otto C, Schildhaus HU, Agaimy A. Histopathology; 2014 Feb 24; 64(3):421-30. PubMed ID: 24266839 [Abstract] [Full Text] [Related]
36. Malignancies associated with GIST: a retrospective study with molecular analysis of KIT and PDGFRA. Mayr P, Märkl B, Agaimy A, Kriening B, Dintner S, Schenkirsch G, Schneider-Stock R. Langenbecks Arch Surg; 2019 Aug 24; 404(5):605-613. PubMed ID: 30877378 [Abstract] [Full Text] [Related]
37. Gastrointestinal Stromal Tumors. von Mehren M, Joensuu H. J Clin Oncol; 2018 Jan 10; 36(2):136-143. PubMed ID: 29220298 [Abstract] [Full Text] [Related]
38. High-resolution melting analysis is a sensitive diagnostic tool to detect imatinib-resistant and imatinib-sensitive PDGFRA exon 18 mutations in gastrointestinal stromal tumors. Künstlinger H, Binot E, Merkelbach-Bruse S, Huss S, Wardelmann E, Buettner R, Schildhaus HU. Hum Pathol; 2014 Mar 10; 45(3):573-82. PubMed ID: 24444465 [Abstract] [Full Text] [Related]
39. Silencing of adaptor protein SH3BP2 reduces KIT/PDGFRA receptors expression and impairs gastrointestinal stromal tumors growth. Serrano-Candelas E, Ainsua-Enrich E, Navinés-Ferrer A, Rodrigues P, García-Valverde A, Bazzocco S, Macaya I, Arribas J, Serrano C, Sayós J, Arango D, Martin M. Mol Oncol; 2018 Aug 10; 12(8):1383-1397. PubMed ID: 29885053 [Abstract] [Full Text] [Related]
40. Gastric GISTs: Analysis of c-Kit, PDGFRA and BRAF mutations in relation to prognosis and clinical pathological characteristics of patients - A GIRCG study. Capelli L, Petracci E, Quagliuolo V, Saragoni L, Colombo P, Morgagni P, Calistri D, Tomezzoli A, Di Cosmo M, Roviello F, Vindigni C, Coniglio A, Villanacci V, Catarci M, Coppola L, Alfieri S, Ricci R, Capella C, Rausei S, Gulino D, Amadori D, Ulivi P, Italian Gastric Cancer Research Group (GIRCG). Eur J Surg Oncol; 2016 Aug 10; 42(8):1206-14. PubMed ID: 27265040 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]